BTG plc Annual Report and Accounts 2015 Five year financial record For the years ended 31 March Consolidated Income statement 1, 4 2, 4 4 3 2015 2014 2013 2012 2011 m m m m m Revenue 367.8 290.5 233.7 197.0 111.4 Cost of sales 114.7 95.0 67.2 56.3 34.1 Gross profit 253.1 195.5 166.5 140.7 77.3 Selling, general and administrative expenses 124.8 84.0 58.0 48.9 33.7 Contribution 128.3 111.5 108.5 91.8 43.6 Amortisation and impairment of acquired intangible assets 28.4 23.3 43.4 30.7 10.0 Amortisation of repurchase of contractual rights 9.6 Foreign exchange gains losses 6.7 5.0 3.1 2.6 2.0 Research and development 68.3 47.2 41.2 39.7 32.1 Profit on disposal of assets and investments 0.3 1.1 0.4 0.2 1.5 Amounts written off property, plant and equipment 1.8 3.0 Amounts written off associates and investments 0.2 1.4 Acquisition and reorganisation costs 3.7 9.8 0.1 1.1 3.8 Operating profit loss 34.9 27.3 25.7 19.9 13.8 Net financial expense income 8.2 6.0 1.6 3.1 3.0 Profit loss before tax 26.7 33.3 24.1 23.0 10.8 Tax credit charge 6.9 9.0 7.7 8.4 20.0 Profit loss after tax for the year 33.6 24.3 16.4 14.6 9.2 Earnings per share Basic 9.1p 6.8p 5.0p 4.5p 3.4p Diluted 9.0p 6.7p 5.0p 4.4p 3.4p 1 The results for the year ended 31 March 2015 include the results of PneumRx Inc. from the date of acquisition, being 7 January 2015.
2 The results for the year ended 31 March 2014 include the results of EKOS Corporation and the Targeted Therapies division of Nordion Inc. from the date of acquisition, being 5 July 2013 and 13 July 2013 respectively.
3 The results for the year ended 31 March 2011 include the results of Biocompatibles International plc from the date of acquisition, being 27 January 2011.
4 Only financial years 2015, 2014 and 2013 reflect IAS 19 revised.
2 The statement of financial position for 31 March 2014 includes the assets and liabilities acquired from EKOS Corporation and the Targeted Therapies division of Nordion Inc. during the year.
3 The statement of financial position for 31 March 2011 includes the assets and liabilities acquired from Biocompatibles International plc during the year.
Consolidated cash flow statement 1 4 2 4 4 3 2015 2014 2013 2012 2011 m m m m m Net cash from used in operating activities 47.5 48.5 55.5 47.2 12.0 Net cash used in investing activities 158.9 269.4 4.5 3.9 5.5 Net cash from used in financing activities 146.2 102.7 0.2 0.2 0.6 Increase decrease in cash and cash equivalents 34.8 118.2 51.2 43.1 18.1 Effect of exchange rate fluctuations on cash held 0.8 2.3 0.6 0.1 0.8 Cash and cash equivalents at start of year 38.2 158.7 106.9 63.7 82.6 Cash and cash equivalents at end of year 73.8 38.2 158.7 106.9 63.7 1 The results for the year ended 31 March 2015 include the results of PneumRx Inc. from the date of acquisition, being 7 January 2015.
130 2 The results for the year ended 31 March 2014 include the results of EKOS Corporation and the Targeted Therapies division of Nordion Inc. from the date of acquisition, being 5 July 2013 and 13 July 2013 respectively.
Financials 3 The results for the year ended 31 March 2011 include the results of Biocompatibles International plc from the date of acquisition, being 27 January 2011.
BTG plc Annual Report and Accounts 2015 Shareholder information Financial calendar Circulation of Annual Report for the year ended 31 March 2015 12 June 2015 Annual General Meeting 15 July 2015 Announcement of interim results for the six months ended 30 September 2015 November 2015 Preliminary announcement of annual results for the year ended 31 March 2016 May 2016 Shareholders At 31 March 2015 there were 9,361 holders of ordinary shares in the Company.
Their shareholdings are analysed as follows: Percentage of Number of total number of Number of Percentage of Size of shareholding shareholders shareholders ordinary shares ordinary shares 1 5,000 8,581 91.7 5,751,097 1.5 5,001 50,000 510 5.4 7,845,609 2.0 50,001 100,000 70 0.7 4,919,503 1.3 100,001 500,000 111 1.2 25,467,777 6.7 Over 500,000 89 1.0 337,792,717 88.5 Total 9,361 100.0 381,776,703 100.0 Shareholders are further analysed as follows: Percentage of Number of total number of Number of Percentage of Type of owner shareholders shareholders ordinary shares ordinary shares Bank and nominee companies 1,059 11.3 370,316,414 97.0 Private shareholders 8,126 86.8 10,148,882 2.7 Limited companies 58 0.6 410,271 0.1 BTG Employee Share Trust 1 321,341 0.1 Insurance companies and pension funds 117 1.3 579,795 0.1 9,361 100.0 381,776,703 100.0 Mutual funds and other institutions, and private shareholders holding their shares within PEPs and ISAs, are included within Bank and nominee companies.
Capita share dealing services A quick and easy share dealing service is available from Capita Asset Services, to either buy or sell more shares.
An online and telephone dealing facility is available providing shareholders with an easy-to-access and simple-to-use service.
For further information on this service, or to buy and sell shares, please contact: www.
com online dealing or 44 0 871 664 0446 telephone dealing calls cost 10p per minute plus network extras.
Lines are open from 8 am to 4.30 pm, Monday to Friday If calling from outside the UK: 44 0 20 3367 2686.
Full terms, conditions and risks apply and are available on request or by visiting www.
This is not a recommendation to buy or sell shares.
The price of shares can go down as well as up, and you are not guaranteed to get back the amount that you originally invested.
Shareholder change of address 131 The Company offers the facility, in conjunction with Capita Asset Services, our Registrars, to conduct a number of routine Financials matters via the web including the ability to notify any change of address.
If you are a shareholder and are either unable or would prefer not to use this facility, please do not send the notification to the Companys registered office.
Please write direct to Capita, at their address shown below, where the register is held.
Registered office and head office BTG plc 5 Fleet Place London EC4M 7RD Telephone: 44 0 20 7575 0000 Facsimile: 44 0 20 7575 0010 Email: info@btgplc.
